Pubdate: Tue, 18 Apr 2006 Source: Star-Ledger (Newark, NJ) Copyright: 2006 Newark Morning Ledger Co Contact: http://www.nj.com/starledger/ Details: http://www.mapinc.org/media/424 Author: Jeff Whelan And Josh Margolin Bookmark: http://www.mapinc.org/find?137 (Needle Exchange) STALLING ON TWO SENSITIVE BILLS ANGERS CORZINE Governor Vows To Push Lawmakers For Needle-Swap And Stem Cell Laws Frustrated by a deadlock in the Legislature, Gov. Jon Corzine vowed yesterday to use the bully pulpit of his office to push through controversial measures to legalize needle exchanges for drug users and to boost stem cell research. Corzine said he had hoped both initiatives would be enacted by now but that each has stalled because "the legislative process has the ability to tie it up in knots." The governor called it "unconscionable" that New Jersey leaders have "sat on our hands," failing to establish a program to give intravenous drug users access to clean needles to help prevent the spread of the AIDS virus. Delaware is the only other state that prohibits both the sale of syringes and their distribution through needle exchanges. Corzine also criticized inaction on legislation to invest up to $250 million in stem cell research. He said the delay would hurt New Jersey's efforts to become a leader in the research as Maryland and other states push forward. He said legislative maneuvering has intertwined the stem cell bill's fate with that of the needle exchange program. "Stem cell needs to happen and needle exchange needs to happen for substantive reasons," Corzine said in an interview yesterday. He said he will seek to bring public pressure on the Legislature, controlled by his fellow Democrats, to enact the needle exchange legislation in order to jump-start both measures. "This really needs to get moved up in the agenda. I'm going to start talking about the issue over and over again," the governor said. New Jersey has the fifth-highest rate of HIV infection in the country, and more than half its cases can be linked to injection drug use. Advocates have pushed to legalize needle exchanges for years, but opponents, notably state Sen. Ronald Rice (D-Newark), argue the program would encourage addiction and perpetuate urban poverty. The measure passed the Assembly in the last legislative session but stalled in the Senate. That has frustrated Assembly Speaker Joseph Roberts (D-Camden), one of the measure's key proponents. "The days of allowing one senator to block progress on this issue ... needs to end," Roberts said yesterday. Rice, who is running for mayor of Newark, did not return calls for comment. According to two administration officials and another high-ranking Democrat, Roberts has refused to allow further Assembly action on stem cell research until the Senate moves on the needle exchange bill. In response, Roberts would say only he is hopeful the Legislature will approve both measures in voting sessions next month. "I think it's important to address both of those issues. Stem cell research is about the promise of saving lives tomorrow, and access to clean needles is about saving lives today," Roberts said. "No one is going to put this (needle exchange) bill in their campaign brochure because this got passed, but there are times when you have to do the right thing because it's the right thing." In contrast, Democrats have used stem cell research as a campaign issue, and Corzine made it a cornerstone of his platform in last year's governor's race. Still, the matter has been controversial because much of the research involves stem cells taken from human embryos. The resulting destruction of embryos is immoral, say some critics of the research. Others question the spending in tight budget times. Plans call for the state to build a $150 million Stem Cell Research Institute on the Rutgers University campus in New Brunswick; a $50 million biomedical research facility at Rutgers in Camden as a joint venture with the Coriell Institute for Medical Research; and a $50 million laboratory at the New Jersey Institute of Technology in Newark. The money would come from the previously authorized sale of bonds to be repaid from cigarette tax revenue. The Senate and Assembly still would have to iron out differences in competing bills. By tying the needle exchange bill to the stem cell funding, Roberts also is hitching one of Senate President Richard Codey's (D-Essex) biggest priorities. Codey supports the needle exchange plan, although he hasn't picked a fight with Rice over it. Asked yesterday about Corzine's renewed effort on that issue, Codey said: "There's nothing wrong with fighting for what you believe in. It's fine with me." The needle exchange controversy has stymied dozens of appointments of Essex County residents to state boards and commissions since last fall. Sen. Nia Gill (D-Essex) has invoked the unwritten rule of "senatorial courtesy" to block all gubernatorial appointments of Essex residents until there is a vote on the Senate floor to legalize needle exchange. "With Governor Corzine's leadership, we will be able to let it out of committee and have a full and fair debate on it," Gill said. "This is a fight that has continued for more than a decade." John Tomicki, executive director of the League of American Families, said yesterday there is "no good medical evidence to show that (needle exchanges) will reduce in any way, shape or form drug addiction or medical abuse." His organization also opposes embryonic stem cell research. Tomicki added of Corzine, "He's pursuing a ridiculous political agenda and he is not following good health care that will lead to saving lives." Marie Tasy of New Jersey Right to Life, an anti-abortion group, said: "All of these programs are being cut and the taxes are being raised at the same time he is pursuing research that is immoral, impractical, unproven and unethical." Staff writer Susan K. Livio contributed to this report. Jeff Whelan and Josh Margolin cover state government and politics. - --- MAP posted-by: Beth Wehrman